Evidence map›Paper›PMID 8252812›Full record

ArticleClinical and experimental immunology1993

Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism.

A I Roberts, S M O'Connell, L Biancone, R E Brolin, E C Ebert

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 66 citations in OpenAlex.

  1. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Alpha E beta 7.Molecular pathology : MP · 1999
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A I RobertsDepartment of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019.
S M O'Connell
L Biancone
R E Brolin
E C Ebert
Johnson University · US

Funding

INTRAEPITHELIAL LYMPHOCYTES RELATION TO EPITHELIAL CELLSR01DK042166 · NIDDK · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI EBERT, ELLEN CATHERINE · 1990 to 2002
$654k
NIDDK NIH HHS DK 42166
6 · The paper itself

Abstract

Human intestinal intraepithelial lymphocytes (IEL) demonstrate target cell-restricted spontaneous cytotoxic (SC) activity that is due to CD2+CD3+CD8+CD16-CD56- effector cells; they kill epithelial cell (EC) tumours (such as DLD-1 colon cancer cells), but not natural killer (NK)-sensitive K-562 cells. The present study shows that the measured levels of SC activities by IEL correlated with those of autologous lamina propria lymphocytes (LPL), but not with those of peripheral blood lymphocytes (PBL). Also, the susceptibilities of DLD-1 cell clones to lysis by IEL and PBL effector cells did not correlate, suggesting different mechanisms of lysis. Antibody blocking experiments showed that the main surface molecules involved in lysis depended on the effector cell type: alpha E beta 7 (HML-1) on IEL and CD16 on PBL. No antibody-dependent cell-mediated cytotoxicity (ADCC) was demonstrated by IEL, even after stimulation with interferon-gamma (IFN-gamma). Few IEL expressed Fc receptors for IgG. This study describes further differences between the SC activities of IEL and PBL.

Indexed as

Cytotoxicity, ImmunologicAntibody-Dependent Cell CytotoxicityAntigens, CDFlow CytometryHumansIntestinal MucosaJejunumKiller Cells, NaturalLymphocytesReceptors, IgGTumor Cells, CulturedAntigens, CDReceptors, IgG

Identifiers

PMID8252812
PMCPMC1534451
OpenAlexW2093250647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.